NACDS praises CMS on first round funding for Rural Health Transformation Program
FY26 funding amounts released as NACDS urges states to implement pharmacy-centered solutions.
FY26 funding amounts released as NACDS urges states to implement pharmacy-centered solutions.
CMS made funding awards to all 50 states.
Companion provides insights on partnerships for improving medication use quality.
The approval expands the Wegovy portfolio beyond injections, providing a new administration option for patients.
This initiative aligns with PTCB's commitment to the advancement of the entire pharmacy technician field.
Activity is ramping up across most U.S. regions, with spikes in the Northeast and the Mountain West, as the new subclade K variant emerges and may affect population immunity.
The agreements reduce prices on drugs that treat numerous costly and chronic conditions.
The company has committed more than $70 billion in U.S. investments to boost domestic production and innovation.
Google Trends analysis revealed that new types of health-related searches emerged in the second half of 2025 and will continue into next year.
The end of enhanced ACA premium support in 2026 will likely push millions off marketplace plans, increasing uninsured visits to safety-net clinics and assistance programs.
APhA believes that moving marijuana to Schedule III will help accelerate research into its medicinal applications and potentially lead to safer and more effective therapeutic uses.
Meaningful reform must address three key issues: transparency, fair pharmacy reimbursement, and ending PBM spread pricing.
It marks the first time American clinicians will be able to prescribe a novel non-drug therapy called transcranial direct current stimulation (tDCS) for at-home use.
The Discount Finder offers customers a quick and straightforward way to find lower prices on most prescriptions at Publix Pharmacy.
This action bypasses House leadership and ensures a vote as early as January 2026, after the subsidies expire under current law.
National pharmacy organizations warn Congress that failure to curb abusive PBM practices has escalated from an emerging threat to an unaddressed crisis for patients and pharmacies.